Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > GREAT NEWS OUT

<< Previous

Bullboard Posts

Next >>

Comment by ssdasmmon Feb 09, 2021 12:50pm

138 Views

Post# 32514011

RE:RE:GREAT NEWS OUT

MBX WILL have a contract with the Ontario Government, that's a given. One important take away of this release is that they have customers outside of the Ontario Government lining up to buy there product at there targeted price. If the private market is buying it you know the product and price is good. IMO

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”